They've been approving a handful of medicines each month (usually 2 to 4). Approvals can come at any time; I made a post about this recently. Note that decisions aren't handed out in the order the applications were received, so I don't mean to imply that those other 2 medicines need to be approved before DCVax-L can get a decision. I only mention them to point out that there is a maximum of just 2 open NAS applications "ahead" of DCVax-L competing for investigative resources; there is no backlog of NAS applications investigators need to wade through in order to get to our application.
Market Data 
Markets 
AI
